Bio
Dr. Hiesinger is a board-certified, fellowship-trained specialist in adult cardiac surgery. He is also an assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
Dr. Hiesinger’s clinical focus encompasses the full spectrum of cardiothoracic conditions and treatment approaches, such as heart transplantation, lung transplantation, mitral and aortic valve repair, cardiomyopathy surgical treatment, and coronary artery bypass procedures. He serves as Surgical Director of the Stanford Mechanical Circulatory Support Program, where he leads and directs the surgical implantation of ventricular assist devices (VADs) in patients with end-stage heart failure.
The National Institutes of Health and the Thoracic Surgery Foundation have awarded funds to support Dr. Hiesinger’s research. In the Stanford Cardiothoracic Therapeutics and Surgery Laboratory, he investigates innovations such as bioengineered devices, tissue engineering, and angiogenic cytokine therapy for the treatment of ischemic heart failure.
He has published extensively on new techniques in ventricular assist device implantation, advances in life support for cardiac failure, cell transplantation in heart failure, and many other topics. His work has appeared in the Journal of Thoracic and Cardiovascular Surgery, Journal of Vascular Surgery, Journal of Cardiac Failure, Current Treatment Options in Cardiovascular Medicine, and elsewhere. In addition, Dr. Hiesinger is a reviewer for the publication Circulation.
He teaches courses on cardiothoracic surgery skills. He also advises surgeons of the future.
Dr. Hiesinger has won awards for his research and scholarship, including the Surgical Resident of the Year Award, Jonathan E. Rhoads Research Award, Clyde F. Baker Research Prize, and I.S. Ravdin Prize, all from his alma mater, the University of Pennsylvania. He was a finalist for the Vivien Thomas Young Investigator Award from the American Heart Association.
Dr. Hiesinger is a member of the Society of Thoracic Surgeons and serves on the Workforce on Surgical Treatment of End-Stage Cardiopulmonary Disease national committee. He is also a member of the American Heart Association Council for Cardiothoracic and Vascular Surgery.
